Advertisement
A live Web cast and recording of the presentation will be available onlinefrom the investor relations page of the Company's corporate Web site athttp://www.cryocor.com. The recording will remain available on CryoCor's Website for at least 30 days following presentation.
Advertisement
About CryoCor
CryoCor is a medical technology company that has developed andmanufactures a disposable catheter system based on its proprietarycryoablation technology for the minimally invasive treatment of cardiacarrhythmias. The Company's product, the CryoCor Cardiac Cryoablation System,or the Cryoablation System, is designed to treat cardiac arrhythmias throughthe use of cryoenergy, or extreme cold, to destroy targeted cardiac tissue.The Cryoablation System has been approved in Europe for the treatment ofatrial fibrillation and atrial flutter, the two most common and difficult totreat arrhythmias, since 2002. In the United States, CryoCor has completedenrollment in a pivotal trial to evaluate the safety and efficacy of theCryoablation System for the treatment of atrial fibrillation and theCryoablation System has been approved in the United States for the treatmentof right atrial flutter. For more information please visit the Company'swebsite at http://www.cryocor.com.Contact: CryoCor, Inc. The Ruth Group Gregory J. Tibbitts Nick Laudico / Zack Kubow (investors) Chief Financial Officer (646) 536-7030 / 7020 (858) 909-2200 [email protected] [email protected] [email protected] Jason Rando (media) (646) 536-7025 [email protected]
SOURCE CryoCor, Inc.
